{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:12:23Z","timestamp":1794622343227,"version":"4.9.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG046170"],"award-info":[{"award-number":["U01AG046170"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG057907"],"award-info":[{"award-number":["R01AG057907"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG070710"],"award-info":[{"award-number":["R03AG070710"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2018253F"],"award-info":[{"award-number":["A2018253F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2016482F"],"award-info":[{"award-number":["A2016482F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mount Sinai Alzheimer\u2019s Disease Research Center","award":["AG005138"],"award-info":[{"award-number":["AG005138"]}]},{"name":"Mount Sinai Alzheimer\u2019s Disease Research Center","award":["P30AG066514"],"award-info":[{"award-number":["P30AG066514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    TYROBP (also known as DAP12 or KARAP) is a transmembrane adaptor protein initially described as a receptor-activating subunit component of natural killer (NK) cells. TYROBP is expressed in numerous cell types, including peripheral blood monocytes, macrophages, dendritic cells, and osteoclasts, but a key point of recent interest is related to the critical role played by TYROBP in the function of many receptors expressed on the plasma membrane of microglia. TYROBP is the downstream adaptor and putative signaling partner for several receptors implicated in Alzheimer\u2019s disease (AD), including SIRP1\u03b2, CD33, CR3, and TREM2. TYROBP has received much of its current notoriety because of its importance in brain homeostasis by signal transduction across those receptors. In this review, we provide an overview of evidence indicating that the biology of TYROBP extends beyond its interaction with these four ligand-binding ectodomain-intramembranous domain molecules. In addition to reviewing the structure and localization of TYROBP, we discuss our recent progress using mouse models of either cerebral amyloidosis or tauopathy that were engineered to be TYROBP-deficient or TYROBP-overexpressing. Remarkably, constitutively TYROBP-deficient mice provided a model of genetic resilience to either of the defining proteinopathies of AD. Learning behavior and synaptic electrophysiological function were preserved at normal physiological levels even in the face of robust cerebral amyloidosis (in\n                    <jats:italic>APP\/PSEN1<\/jats:italic>\n                    ;\n                    <jats:italic>Tyrobp<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice) or tauopathy (in\n                    <jats:italic>MAPT<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>P301S<\/jats:italic>\n                    <\/jats:sup>\n                    ;\n                    <jats:italic>Tyrobp<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice). A fundamental underpinning of the functional synaptic dysfunction associated with each proteotype was an accumulation of complement C1q. TYROBP deficiency prevented C1q accumulation associated with either proteinopathy. Based on these data, we speculate that TYROBP plays a key role in the microglial sensome and the emergence of the disease-associated microglia (DAM) phenotype. TYROBP may also play a key role in the loss of markers of synaptic integrity (e.g., synaptophysin-like immunoreactivity) that has long been held to be the feature of human AD molecular neuropathology that most closely correlates with concurrent clinical cognitive function.\n                  <\/jats:p>","DOI":"10.1186\/s13024-022-00552-w","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:03:42Z","timestamp":1661339022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Microglial TYROBP\/DAP12 in Alzheimer\u2019s disease: Transduction of physiological and pathological signals across TREM2"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-9666","authenticated-orcid":false,"given":"Jean-Vianney","family":"Haure-Mirande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-7380","authenticated-orcid":false,"given":"Mickael","family":"Audrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9397-686X","authenticated-orcid":false,"given":"Michelle E.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-4721","authenticated-orcid":false,"given":"Sam","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"552_CR1","doi-asserted-by":"publisher","first-page":"29639","DOI":"10.1074\/jbc.R800016200","volume":"283","author":"CG Glabe","year":"2008","unstructured":"Glabe CG. Structural classification of toxic amyloid oligomers. J Biol Chem. 2008;283:29639\u201343.","journal-title":"J Biol Chem"},{"key":"552_CR2","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron. 2013;79:887\u2013902.","journal-title":"Neuron"},{"key":"552_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13041-015-0111-4","volume":"8","author":"F Raka","year":"2015","unstructured":"Raka F, Di Sebastiano AR, Kulhawy SC, Ribeiro FM, Godin CM, Caetano FA, et al. Ca2+\/Calmodulin-dependent protein Kinase II interacts with group I Metabotropic Glutamate and facilitates Receptor Endocytosis and ERK1\/2 signaling: role of \u03b2-Amyloid. Molecular brain. 2015;8:21.","journal-title":"Molecular brain"},{"key":"552_CR4","first-page":"E1230","volume":"111","author":"G Joshi","year":"2014","unstructured":"Joshi G, Chi Y, Huang Z, Wang Y. Abeta-induced Golgi fragmentation in Alzheimer\u2019s disease enhances Abeta production. Proc Natl Acad Sci USA. 2014;111:E1230\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"552_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990;40:1\u20138.","journal-title":"Neurology"},{"key":"552_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000;10:378\u201384.","journal-title":"Brain Pathol"},{"key":"552_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. alpha-synuclein in the pathophysiology of Alzheimer's disease. Mol Neurodegener. 2019;14:23.","journal-title":"Mol Neurodegener"},{"key":"552_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-021-00486-9","volume":"16","author":"GM Lloyd","year":"2021","unstructured":"Lloyd GM, Dhillon JS, Gorion KM, Riffe C, Fromholt SE, Xia Y, et al. Collusion of alpha-Synuclein and Abeta aggravating co-morbidities in a novel prion-type mouse model. Mol Neurodegener. 2021;16:63.","journal-title":"Mol Neurodegener"},{"key":"552_CR9","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 2008;28:8354\u201360.","journal-title":"J Neurosci"},{"key":"552_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","volume":"586","author":"A Badimon","year":"2020","unstructured":"Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, et al. Negative feedback control of neuronal activity by microglia. Nature. 2020;586:417\u201323.","journal-title":"Nature"},{"key":"552_CR11","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164\u201378.","journal-title":"Cell"},{"key":"552_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691\u2013705.","journal-title":"Neuron"},{"key":"552_CR13","doi-asserted-by":"publisher","first-page":"a020545","DOI":"10.1101\/cshperspect.a020545","volume":"7","author":"DP Schafer","year":"2015","unstructured":"Schafer DP, Stevens B. Microglia Function in Central Nervous System Development and Plasticity. Cold Spring Harb Perspect Biol. 2015;7:a020545.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"552_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456\u20138.","journal-title":"Science"},{"key":"552_CR15","doi-asserted-by":"publisher","first-page":"16064","DOI":"10.1523\/JNEUROSCI.4158-11.2011","volume":"31","author":"ME Tremblay","year":"2011","unstructured":"Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci. 2011;31:16064\u20139.","journal-title":"J Neurosci"},{"key":"552_CR16","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","volume":"33","author":"AH Stephan","year":"2013","unstructured":"Stephan AH, Madison DV, Mateos JM, Fraser DA, Lovelett EA, Coutellier L, et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci. 2013;33:13460\u201374.","journal-title":"J Neurosci"},{"key":"552_CR17","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130:1912\u201330.","journal-title":"J Clin Invest"},{"key":"552_CR18","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"552_CR19","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","volume":"38","author":"L Rajendran","year":"2018","unstructured":"Rajendran L, Paolicelli RC. Microglia-Mediated Synapse Loss in Alzheimer's Disease. J Neurosci. 2018;38:2911\u20139.","journal-title":"J Neurosci"},{"key":"552_CR20","doi-asserted-by":"crossref","unstructured":"Feng B, Freitas AE, Gorodetski L, Wang J, Tian R, Lee YR, et al. Planar cell polarity signaling components are a direct target of beta-amyloid-associated degeneration of glutamatergic synapses. Sci Adv. 2021;7(eabh2307).","DOI":"10.1126\/sciadv.abh2307"},{"key":"552_CR21","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.1073\/pnas.1612062114","volume":"114","author":"S Thakar","year":"2017","unstructured":"Thakar S, Wang L, Yu T, Ye M, Onishi K, Scott J, et al. Evidence for opposing roles of Celsr3 and Vangl2 in glutamatergic synapse formation. Proc Natl Acad Sci U S A. 2017;114:E610\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"552_CR22","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41:1094\u20139.","journal-title":"Nat Genet"},{"key":"552_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"552_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"issue":"566-581","key":"552_CR25","first-page":"e569","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(566-581):e569.","journal-title":"Immunity"},{"issue":"1276-1290","key":"552_CR26","first-page":"e1217","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell. 2017;169(1276-1290):e1217.","journal-title":"Cell"},{"key":"552_CR27","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.stemcr.2017.04.023","volume":"8","author":"P Douvaras","year":"2017","unstructured":"Douvaras P, Sun B, Wang M, Kruglikov I, Lallos G, Zimmer M, et al. Directed Differentiation of Human Pluripotent Stem Cells to Microglia. Stem Cell Reports. 2017;8:1516\u201324.","journal-title":"Stem Cell Reports"},{"key":"552_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Gaiteri C, Bodea LG, Wang Z, McElwee J, Podtelezhnikov AA, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013;153:707\u201320.","journal-title":"Cell"},{"key":"552_CR29","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16:1896\u2013905.","journal-title":"Nat Neurosci"},{"key":"552_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/alz.12256","volume":"17","author":"M Audrain","year":"2021","unstructured":"Audrain M, Haure-Mirande JV, Mleczko J, Wang M, Griffin JK, St George-Hyslop PH, et al. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice. Alzheimers Dement. 2021;17:149\u201363.","journal-title":"Alzheimers Dement"},{"key":"552_CR31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41380-018-0258-3","volume":"24","author":"M Audrain","year":"2019","unstructured":"Audrain M, Haure-Mirande JV, Wang M, Kim SH, Fanutza T, Chakrabarty P, et al. Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in a tauopathy mouse model reduces C1q and normalizes clinical phenotype while increasing spread and state of phosphorylation of tau. Mol Psychiatry. 2019;24:1383\u201397.","journal-title":"Mol Psychiatry"},{"key":"552_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41380-018-0255-6","volume":"24","author":"JV Haure-Mirande","year":"2019","unstructured":"Haure-Mirande JV, Wang M, Audrain M, Fanutza T, Kim SH, Heja S, et al. Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Abeta amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Abeta burden. Mol Psychiatry. 2019;24:431\u201346.","journal-title":"Mol Psychiatry"},{"key":"552_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00401-017-1737-3","volume":"134","author":"JV Haure-Mirande","year":"2017","unstructured":"Haure-Mirande JV, Audrain M, Fanutza T, Kim SH, Klein WL, Glabe C, et al. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology. Acta Neuropathol. 2017;134:769\u201388.","journal-title":"Acta Neuropathol"},{"key":"552_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40268-019-0266-z","volume":"19","author":"AJ Fowler","year":"2019","unstructured":"Fowler AJ, Hebron M, Missner AA, Wang R, Gao X, Kurd-Misto BT, et al. Multikinase Abl\/DDR\/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration. Drugs R D. 2019;19:149\u201366.","journal-title":"Drugs R D"},{"key":"552_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","volume":"85","author":"P Chakrabarty","year":"2015","unstructured":"Chakrabarty P, Li A, Ceballos-Diaz C, Eddy JA, Funk CC, Moore B, et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron. 2015;85:519\u201333.","journal-title":"Neuron"},{"key":"552_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1742-2094-2-22","volume":"2","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Dewachter I, Walter J, Klockgether T, et al. Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP [V717I] transgenic mice. J Neuroinflammation. 2005;2:22.","journal-title":"J Neuroinflammation"},{"key":"552_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"WS Griffin","year":"1998","unstructured":"Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, et al. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 1998;8:65\u201372.","journal-title":"Brain Pathol"},{"key":"552_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0169-328X(97)00356-2","volume":"55","author":"GE Ringheim","year":"1998","unstructured":"Ringheim GE, Szczepanik AM, Petko W, Burgher KL, Zhu SZ, Chao CC. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor\/interleukin-6 complex. Brain Res Mol Brain Res. 1998;55:35\u201344.","journal-title":"Brain Res Mol Brain Res"},{"key":"552_CR39","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.4049\/jimmunol.158.11.5083","volume":"158","author":"L Olcese","year":"1997","unstructured":"Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 1997;158:5083\u20136.","journal-title":"J Immunol"},{"key":"552_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/35642","volume":"391","author":"LL Lanier","year":"1998","unstructured":"Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 1998;391:703\u20137.","journal-title":"Nature"},{"key":"552_CR41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4049\/jimmunol.161.1.7","volume":"161","author":"KM Smith","year":"1998","unstructured":"Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol. 1998;161:7\u201310.","journal-title":"J Immunol"},{"key":"552_CR42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature06901","volume":"453","author":"JS Ziegenfuss","year":"2008","unstructured":"Ziegenfuss JS, Biswas R, Avery MA, Hong K, Sheehan AE, Yeung YG, et al. Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling. Nature. 2008;453:935\u20139.","journal-title":"Nature"},{"key":"552_CR43","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/ni.1943","volume":"11","author":"ME Call","year":"2010","unstructured":"Call ME, Wucherpfennig KW, Chou JJ. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol. 2010;11:1023\u20139.","journal-title":"Nat Immunol"},{"key":"552_CR44","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1371\/journal.pbio.0040142","volume":"4","author":"J Feng","year":"2006","unstructured":"Feng J, Call ME, Wucherpfennig KW. The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. PLoS Biol. 2006;4:e142.","journal-title":"PLoS Biol"},{"key":"552_CR45","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","volume":"177","author":"JA Hamerman","year":"2006","unstructured":"Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol. 2006;177:2051\u20135.","journal-title":"J Immunol"},{"key":"552_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ni1204","volume":"6","author":"JA Hamerman","year":"2005","unstructured":"Hamerman JA, Tchao NK, Lowell CA, Lanier LL. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol. 2005;6:579\u201386.","journal-title":"Nat Immunol"},{"key":"552_CR47","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","volume":"177","author":"IR Turnbull","year":"2006","unstructured":"Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 2006;177:3520\u20134.","journal-title":"J Immunol"},{"key":"552_CR48","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1182\/blood-2004-12-4802","volume":"106","author":"A Fuchs","year":"2005","unstructured":"Fuchs A, Cella M, Kondo T, Colonna M. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood. 2005;106:2076\u201382.","journal-title":"Blood"},{"key":"552_CR49","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nri2014","volume":"7","author":"IR Turnbull","year":"2007","unstructured":"Turnbull IR, Colonna M. Activating and inhibitory functions of DAP12. Nat Rev Immunol. 2007;7:155\u201361.","journal-title":"Nat Rev Immunol"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-065X.2008.00720.x","volume":"227","author":"LL Lanier","year":"2009","unstructured":"Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev. 2009;227:150\u201360.","journal-title":"Immunol Rev"},{"key":"552_CR51","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-981-15-1580-4_9","volume":"1204","author":"T Angata","year":"2020","unstructured":"Angata T. Siglecs that Associate with DAP12. Adv Exp Med Biol. 2020;1204:215\u201330.","journal-title":"Adv Exp Med Biol"},{"key":"552_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4049\/jimmunol.164.1.9","volume":"164","author":"J Dietrich","year":"2000","unstructured":"Dietrich J, Cella M, Seiffert M, Buhring HJ, Colonna M. Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol. 2000;164:9\u201312.","journal-title":"J Immunol"},{"key":"552_CR53","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/1521-4141(2000)30:8<2147::AID-IMMU2147>3.0.CO;2-1","volume":"30","author":"E Tomasello","year":"2000","unstructured":"Tomasello E, Cant C, Buhring HJ, Vely F, Andre P, Seiffert M, et al. Association of signal-regulatory proteins beta with KARAP\/DAP-12. Eur J Immunol. 2000;30:2147\u201356.","journal-title":"Eur J Immunol"},{"key":"552_CR54","doi-asserted-by":"publisher","first-page":"29450","DOI":"10.1074\/jbc.M400950200","volume":"279","author":"A Hayashi","year":"2004","unstructured":"Hayashi A, Ohnishi H, Okazawa H, Nakazawa S, Ikeda H, Motegi S, et al. Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages. J Biol Chem. 2004;279:29450\u201360.","journal-title":"J Biol Chem"},{"key":"552_CR55","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.2353\/ajpath.2009.090147","volume":"175","author":"S Gaikwad","year":"2009","unstructured":"Gaikwad S, Larionov S, Wang Y, Dannenberg H, Matozaki T, Monsonego A, et al. Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol. 2009;175:2528\u201339.","journal-title":"Am J Pathol"},{"key":"552_CR56","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991\u20135.","journal-title":"J Immunol"},{"key":"552_CR57","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3389\/fimmu.2017.00917","volume":"8","author":"L Fu","year":"2017","unstructured":"Fu L, Han L, Xie C, Li W, Lin L, Pan S, et al. Identification of Extracellular Actin As a Ligand for Triggering Receptor Expressed on Myeloid Cells-1 Signaling. Front Immunol. 2017;8:917.","journal-title":"Front Immunol"},{"key":"552_CR58","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.4049\/jimmunol.1402303","volume":"194","author":"CB Read","year":"2015","unstructured":"Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, et al. Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. J Immunol. 2015;194:1417\u201321.","journal-title":"J Immunol"},{"key":"552_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.imlet.2007.04.011","volume":"111","author":"R El Mezayen","year":"2007","unstructured":"El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett. 2007;111:36\u201344.","journal-title":"Immunol Lett"},{"key":"552_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1684\/ecn.2011.0274","volume":"22","author":"RJ Arts","year":"2011","unstructured":"Arts RJ, Joosten LA, Dinarello CA, Kullberg BJ, van der Meer JW, Netea MG. TREM-1 interaction with the LPS\/TLR4 receptor complex. Eur Cytokine Netw. 2011;22:11\u20134.","journal-title":"Eur Cytokine Netw"},{"key":"552_CR61","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/35074114","volume":"410","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103\u20137.","journal-title":"Nature"},{"key":"552_CR62","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.4049\/jimmunol.0803862","volume":"183","author":"H Lagler","year":"2009","unstructured":"Lagler H, Sharif O, Haslinger I, Matt U, Stich K, Furtner T, et al. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol. 2009;183:2027\u201336.","journal-title":"J Immunol"},{"key":"552_CR63","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, Zheng H, et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem. 2015;290:26043\u201350.","journal-title":"J Biol Chem"},{"key":"552_CR64","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. J Biol Chem. 2015;290:26033\u201342.","journal-title":"J Biol Chem"},{"key":"552_CR65","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Hernandez-Munain C, Cella M, Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med. 2001;194:1111\u201322.","journal-title":"J Exp Med"},{"key":"552_CR66","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","volume":"171","author":"MR Daws","year":"2003","unstructured":"Daws MR, Sullam PM, Niemi EC, Chen TT, Tchao NK, Seaman WE. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol. 2003;171:594\u20139.","journal-title":"J Immunol"},{"key":"552_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-122311","volume":"35","author":"C Pottier","year":"2013","unstructured":"Pottier C, Wallon D, Rousseau S, Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, et al. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. J Alzheimers Dis. 2013;35:45\u20139.","journal-title":"J Alzheimers Dis"},{"key":"552_CR68","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","volume":"74","author":"D Soragna","year":"2003","unstructured":"Soragna D, Papi L, Ratti MT, Sestini R, Tupler R, Montalbetti L. An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene. J Neurol Neurosurg Psychiatry. 2003;74:825\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"934","key":"552_CR69","first-page":"e937","volume":"35","author":"B Borroni","year":"2014","unstructured":"Borroni B, Ferrari F, Galimberti D, Nacmias B, Barone C, Bagnoli S, et al. Heterozygous TREM2 mutations in frontotemporal dementia. Neurobiol Aging. 2014;35(934):e937\u201310.","journal-title":"Neurobiol Aging"},{"key":"552_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/1521-4141(200201)32:1<59::AID-IMMU59>3.0.CO;2-U","volume":"32","author":"DH Chung","year":"2002","unstructured":"Chung DH, Seaman WE, Daws MR. Characterization of TREM-3, an activating receptor on mouse macrophages: definition of a family of single Ig domain receptors on mouse chromosome 17. Eur J Immunol. 2002;32:59\u201366.","journal-title":"Eur J Immunol"},{"key":"552_CR71","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.177.5.2819","volume":"177","author":"A Martinez-Barriocanal","year":"2006","unstructured":"Martinez-Barriocanal A, Sayos J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J Immunol. 2006;177:2819\u201330.","journal-title":"J Immunol"},{"key":"552_CR72","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1073\/pnas.96.17.9792","volume":"96","author":"AB Bakker","year":"1999","unstructured":"Bakker AB, Baker E, Sutherland GR, Phillips JH, Lanier LL. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A. 1999;96:9792\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"552_CR73","doi-asserted-by":"publisher","first-page":"JVI.01813-01816","DOI":"10.1128\/JVI.01813-16","volume":"91","author":"O Teng","year":"2017","unstructured":"Teng O, Chen ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, et al. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol. 2017;91:JVI.01813-01816.","journal-title":"J Virol"},{"key":"552_CR74","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3389\/fimmu.2019.02867","volume":"10","author":"PS Sung","year":"2019","unstructured":"Sung PS, Hsieh SL. CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections. Front Immunol. 2019;10:2867.","journal-title":"Front Immunol"},{"key":"552_CR75","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.4049\/jimmunol.1500978","volume":"196","author":"BW Wortham","year":"2016","unstructured":"Wortham BW, Eppert BL, Flury JL, Garcia SM, Donica WR, Osterburg A, et al. Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease Pathologies. J Immunol. 2016;196:3227\u201331.","journal-title":"J Immunol"},{"key":"552_CR76","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1096\/fj.06-5800com","volume":"20","author":"T Angata","year":"2006","unstructured":"Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J. 2006;20:1964\u201373.","journal-title":"FASEB J"},{"key":"552_CR77","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/glycob\/cwp052","volume":"19","author":"M Yamanaka","year":"2009","unstructured":"Yamanaka M, Kato Y, Angata T, Narimatsu H. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology. 2009;19:841\u20136.","journal-title":"Glycobiology"},{"key":"552_CR78","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/glycob\/cwm049","volume":"17","author":"T Angata","year":"2007","unstructured":"Angata T, Tabuchi Y, Nakamura K, Nakamura M. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution. Glycobiology. 2007;17:838\u201346.","journal-title":"Glycobiology"},{"key":"552_CR79","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1021\/acs.jproteome.7b00625","volume":"16","author":"L Chang","year":"2017","unstructured":"Chang L, Chen YJ, Fan CY, Tang CJ, Chen YH, Low PY, et al. Identification of Siglec Ligands Using a Proximity Labeling Method. J Proteome Res. 2017;16:3929\u201341.","journal-title":"J Proteome Res"},{"key":"552_CR80","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2012.11.036","volume":"53","author":"Y Hiruma","year":"2013","unstructured":"Hiruma Y, Tsuda E, Maeda N, Okada A, Kabasawa N, Miyamoto M, et al. Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice. Bone. 2013;53:87\u201393.","journal-title":"Bone"},{"key":"552_CR81","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/eji.200738078","volume":"38","author":"H Cao","year":"2008","unstructured":"Cao H, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol. 2008;38:2303\u201315.","journal-title":"Eur J Immunol"},{"key":"552_CR82","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2005-09-3746","volume":"107","author":"AL Blasius","year":"2006","unstructured":"Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 2006;107:2474\u20136.","journal-title":"Blood"},{"key":"552_CR83","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/glia.23204","volume":"65","author":"H Konishi","year":"2017","unstructured":"Konishi H, Kobayashi M, Kunisawa T, Imai K, Sayo A, Malissen B, et al. Siglec-H is a microglia-specific marker that discriminates microglia from CNS-associated macrophages and CNS-infiltrating monocytes. Glia. 2017;65:1927\u201343.","journal-title":"Glia"},{"key":"552_CR84","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","volume":"21","author":"JW Ford","year":"2009","unstructured":"Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21:38\u201346.","journal-title":"Curr Opin Immunol"},{"key":"552_CR85","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1074\/jbc.275.6.4467","volume":"275","author":"DD Mousseau","year":"2000","unstructured":"Mousseau DD, Banville D, L'Abbe D, Bouchard P, Shen SH. PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with the truncated counterpart PILRbeta. J Biol Chem. 2000;275:4467\u201374.","journal-title":"J Biol Chem"},{"key":"552_CR86","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1084\/jem.20031885","volume":"199","author":"I Shiratori","year":"2004","unstructured":"Shiratori I, Ogasawara K, Saito T, Lanier LL, Arase H. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med. 2004;199:525\u201333.","journal-title":"J Exp Med"},{"key":"552_CR87","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.4049\/jimmunol.180.3.1686","volume":"180","author":"J Wang","year":"2008","unstructured":"Wang J, Shiratori I, Satoh T, Lanier LL, Arase H. An essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR). J Immunol. 2008;180:1686\u201393.","journal-title":"J Immunol"},{"key":"552_CR88","doi-asserted-by":"publisher","first-page":"8893","DOI":"10.1074\/jbc.M709793200","volume":"283","author":"S Tabata","year":"2008","unstructured":"Tabata S, Kuroki K, Wang J, Kajikawa M, Shiratori I, Kohda D, et al. Biophysical characterization of O-glycosylated CD99 recognition by paired Ig-like type 2 receptors. J Biol Chem. 2008;283:8893\u2013901.","journal-title":"J Biol Chem"},{"key":"552_CR89","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"552_CR90","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neurobiolaging.2014.09.023","volume":"36","author":"DG Walker","year":"2015","unstructured":"Walker DG, Whetzel AM, Serrano G, Sue LI, Beach TG, Lue LF. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Neurobiol Aging. 2015;36:571\u201382.","journal-title":"Neurobiol Aging"},{"key":"552_CR91","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, et al. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78:631\u201343.","journal-title":"Neuron"},{"key":"552_CR92","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood-2007-04-085787","volume":"111","author":"Y Yamanishi","year":"2008","unstructured":"Yamanishi Y, Kitaura J, Izawa K, Matsuoka T, Oki T, Lu Y, et al. Analysis of mouse LMIR5\/CLM-7 as an activating receptor: differential regulation of LMIR5\/CLM-7 in mouse versus human cells. Blood. 2008;111:688\u201398.","journal-title":"Blood"},{"key":"552_CR93","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.4049\/jimmunol.173.11.6703","volume":"173","author":"H Aguilar","year":"2004","unstructured":"Aguilar H, Alvarez-Errico D, Garcia-Montero AC, Orfao A, Sayos J, Lopez-Botet M. Molecular characterization of a novel immune receptor restricted to the monocytic lineage. J Immunol. 2004;173:6703\u201311.","journal-title":"J Immunol"},{"key":"552_CR94","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1006\/bbrc.2001.5539","volume":"287","author":"K Luo","year":"2001","unstructured":"Luo K, Zhang W, Sui L, Li N, Zhang M, Ma X, et al. DIgR1, a novel membrane receptor of the immunoglobulin gene superfamily, is preferentially expressed by antigen-presenting cells. Biochem Biophys Res Commun. 2001;287:35\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"552_CR95","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0006-291X(03)01245-2","volume":"307","author":"H Kumagai","year":"2003","unstructured":"Kumagai H, Oki T, Tamitsu K, Feng SZ, Ono M, Nakajima H, et al. Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun. 2003;307:719\u201329.","journal-title":"Biochem Biophys Res Commun"},{"key":"552_CR96","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.4049\/jimmunol.171.12.6541","volume":"171","author":"DH Chung","year":"2003","unstructured":"Chung DH, Humphrey MB, Nakamura MC, Ginzinger DG, Seaman WE, Daws MR. CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol. 2003;171:6541\u20138.","journal-title":"J Immunol"},{"key":"552_CR97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"552_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"552_CR99","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron. 2016;91:328\u201340.","journal-title":"Neuron"},{"key":"552_CR100","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017;214:597\u2013607.","journal-title":"J Exp Med"},{"key":"552_CR101","doi-asserted-by":"publisher","first-page":"e9027","DOI":"10.15252\/emmm.201809027","volume":"10","author":"CB Lessard","year":"2018","unstructured":"Lessard CB, Malnik SL, Zhou Y, Ladd TB, Cruz PE, Ran Y, et al. High-affinity interactions and signal transduction between Abeta oligomers and TREM2. EMBO Mol Med. 2018;10:e9027.","journal-title":"EMBO Mol Med"},{"key":"552_CR102","doi-asserted-by":"publisher","first-page":"100631","DOI":"10.1016\/j.jbc.2021.100631","volume":"296","author":"A Vilalta","year":"2021","unstructured":"Vilalta A, Zhou Y, Sevalle J, Griffin JK, Satoh K, Allendorf DH, et al. Wild-type sTREM2 blocks Abeta aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Abeta aggregation. J Biol Chem. 2021;296:100631.","journal-title":"J Biol Chem"},{"key":"552_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Suarez-Calvet","year":"2019","unstructured":"Suarez-Calvet M, Morenas-Rodriguez E, Kleinberger G, Schlepckow K, Araque Caballero MA, Franzmeier N, et al. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-beta pathology. Mol Neurodegener. 2019;14:1.","journal-title":"Mol Neurodegener"},{"key":"552_CR104","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z. TREM2 ectodomain and its soluble form in Alzheimer's disease. J Neuroinflammation. 2020;17:204.","journal-title":"J Neuroinflammation"},{"key":"552_CR105","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXI.0000000000000512","volume":"6","author":"M Gisslen","year":"2019","unstructured":"Gisslen M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L, et al. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol Neuroimmunol Neuroinflamm. 2019;6:e512.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"552_CR106","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U","volume":"31","author":"MR Daws","year":"2001","unstructured":"Daws MR, Lanier LL, Seaman WE, Ryan JC. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol. 2001;31:783\u201391.","journal-title":"Eur J Immunol"},{"key":"552_CR107","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1182\/blood-2005-09-3842","volume":"107","author":"J Zhang","year":"2006","unstructured":"Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600\u20138.","journal-title":"Blood"},{"key":"552_CR108","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1182\/blood-2003-09-3108","volume":"103","author":"A Blasius","year":"2004","unstructured":"Blasius A, Vermi W, Krug A, Facchetti F, Cella M, Colonna M. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood. 2004;103:4201\u20136.","journal-title":"Blood"},{"issue":"820-835","key":"552_CR109","first-page":"e827","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, et al. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease. Neuron. 2019;103(820-835):e827.","journal-title":"Neuron"},{"key":"552_CR110","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1128\/MCB.23.12.4199-4206.2003","volume":"23","author":"T Angata","year":"2003","unstructured":"Brinkman-Van der Linden EC, Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A. CD33\/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol. 2003;23:4199\u2013206.","journal-title":"Mol Cell Biol"},{"key":"552_CR111","doi-asserted-by":"publisher","first-page":"11505","DOI":"10.1074\/jbc.274.17.11505","volume":"274","author":"VC Taylor","year":"1999","unstructured":"Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, Freeman SD. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem. 1999;274:11505\u201312.","journal-title":"J Biol Chem"},{"key":"552_CR112","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.0.CO;2-C","volume":"29","author":"T Ulyanova","year":"1999","unstructured":"Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur J Immunol. 1999;29:3440\u20139.","journal-title":"Eur J Immunol"},{"key":"552_CR113","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood.V96.2.483.014k40_483_490","volume":"96","author":"SP Paul","year":"2000","unstructured":"Paul SP, Taylor LS, Stansbury EK, McVicar DW. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood. 2000;96:483\u201390.","journal-title":"Blood"},{"key":"552_CR114","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.cell.2020.06.038","volume":"182","author":"W-T Chen","year":"2020","unstructured":"Chen W-T, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, et al. Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer\u2019s Disease. Cell. 2020;182:976\u2013991.e919.","journal-title":"Cell"},{"key":"552_CR115","doi-asserted-by":"publisher","first-page":"222 e229","DOI":"10.1016\/j.neurobiolaging.2016.07.028","volume":"48","author":"C Pottier","year":"2016","unstructured":"Pottier C, Ravenscroft TA, Brown PH, Finch NA, Baker M, Parsons M, et al. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging. 2016;48:222 e229\u201315.","journal-title":"Neurobiol Aging"},{"key":"552_CR116","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/77153","volume":"25","author":"J Paloneva","year":"2000","unstructured":"Paloneva J, Kestila M, Wu J, Salminen A, Bohling T, Ruotsalainen V, et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet. 2000;25:357\u201361.","journal-title":"Nat Genet"},{"key":"552_CR117","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.celrep.2012.02.014","volume":"1","author":"T Masuda","year":"2012","unstructured":"Masuda T, Tsuda M, Yoshinaga R, Tozaki-Saitoh H, Ozato K, Tamura T, et al. IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 2012;1:334\u201340.","journal-title":"Cell Rep"},{"key":"552_CR118","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d'Errico","year":"2022","unstructured":"d'Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mezo C, Erny D, et al. Microglia contribute to the propagation of Abeta into unaffected brain tissue. Nat Neurosci. 2022;25:20\u20135.","journal-title":"Nat Neurosci"},{"key":"552_CR119","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nn.3318","volume":"16","author":"K Kierdorf","year":"2013","unstructured":"Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci. 2013;16:273\u201380.","journal-title":"Nat Neurosci"},{"key":"552_CR120","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-017-0814-9","volume":"14","author":"MI Fonseca","year":"2017","unstructured":"Fonseca MI, Chu SH, Hernandez MX, Fang MJ, Modarresi L, Selvan P, et al. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflammation. 2017;14:48.","journal-title":"J Neuroinflammation"},{"key":"552_CR121","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3389\/fonc.2020.01765","volume":"10","author":"J Jiang","year":"2020","unstructured":"Jiang J, Ding Y, Wu M, Lyu X, Wang H, Chen Y, et al. Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis. Front Oncol. 2020;10:1765.","journal-title":"Front Oncol"},{"issue":"1322-1336","key":"552_CR122","first-page":"e1327","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Maziere A, Meilandt WJ, Wu T, Srinivasan K, et al. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Neuron. 2018;100(1322-1336):e1327.","journal-title":"Neuron"},{"key":"552_CR123","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/ni.1744","volume":"10","author":"K Otero","year":"2009","unstructured":"Otero K, Turnbull IR, Poliani PL, Vermi W, Cerutti E, Aoshi T, et al. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol. 2009;10:734\u201343.","journal-title":"Nat Immunol"},{"key":"552_CR124","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ni1407","volume":"7","author":"A Mocsai","year":"2006","unstructured":"Mocsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, Lowell CA. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat Immunol. 2006;7:1326\u201333.","journal-title":"Nat Immunol"},{"key":"552_CR125","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.1523\/JNEUROSCI.1006-08.2008","volume":"28","author":"S Wakselman","year":"2008","unstructured":"Wakselman S, Bechade C, Roumier A, Bernard D, Triller A, Bessis A. Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor. J Neurosci. 2008;28:8138\u201343.","journal-title":"J Neurosci"},{"key":"552_CR126","doi-asserted-by":"crossref","unstructured":"Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9.","DOI":"10.1126\/scitranslmed.aaf6295"},{"key":"552_CR127","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, Happonen KE, Burrola PG, O'Connor C, Hah N, Huang L, et al. Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nat Immunol. 2021;22:586\u201394.","journal-title":"Nat Immunol"},{"key":"552_CR128","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ana.24304","volume":"77","author":"O Butovsky","year":"2015","unstructured":"Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015;77:75\u201399.","journal-title":"Ann Neurol"},{"key":"552_CR129","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00401-020-02185-z","volume":"140","author":"B Readhead","year":"2020","unstructured":"Readhead B, Haure-Mirande JV, Mastroeni D, Audrain M, Fanutza T, Kim SH, et al. miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease. Acta Neuropathol. 2020;140:295\u2013315.","journal-title":"Acta Neuropathol"},{"key":"552_CR130","first-page":"539","volume":"23","author":"T Nasu","year":"1973","unstructured":"Nasu T, Tsukahara Y, Terayama K. A lipid metabolic disease-\"membranous lipodystrophy\"-an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol Jpn. 1973;23:539\u201358.","journal-title":"Acta Pathol Jpn"},{"key":"552_CR131","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF00340444","volume":"6","author":"HP Hakola","year":"1973","unstructured":"Hakola HP, Iivanainen M. A new hereditary disease with progressive dementia and polycystic osteodysplasia: neuroradiological analysis of seven cases. Neuroradiology. 1973;6:162\u20138.","journal-title":"Neuroradiology"},{"key":"552_CR132","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1212\/WNL.0000000000004747","volume":"89","author":"L Ghezzi","year":"2017","unstructured":"Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M, et al. Evidence of CNS beta-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation. Neurology. 2017;89:2503\u20135.","journal-title":"Neurology"},{"key":"552_CR133","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5582\/irdr.2017.01088","volume":"7","author":"JI Satoh","year":"2018","unstructured":"Satoh JI, Kino Y, Yanaizu M, Saito Y. Alzheimer's disease pathology in Nasu-Hakola disease brains. Intractable Rare Dis Res. 2018;7:32\u20136.","journal-title":"Intractable Rare Dis Res"},{"key":"552_CR134","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ni0709-681","volume":"10","author":"DW McVicar","year":"2009","unstructured":"McVicar DW, Trinchieri G. CSF-1R, DAP12 and beta-catenin: a menage a trois. Nat Immunol. 2009;10:681\u20133.","journal-title":"Nat Immunol"},{"key":"552_CR135","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ng.1027","volume":"44","author":"R Rademakers","year":"2011","unstructured":"Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2011;44:200\u20135.","journal-title":"Nat Genet"},{"key":"552_CR136","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1126\/science.aau0437","volume":"362","author":"TE Golde","year":"2018","unstructured":"Golde TE, DeKosky ST, Galasko D. Alzheimer's disease: The right drug, the right time. Science. 2018;362:1250\u20131.","journal-title":"Science"},{"key":"552_CR137","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191\u2013204.","journal-title":"Nat Neurosci"},{"key":"552_CR138","doi-asserted-by":"crossref","unstructured":"Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, et al. Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc Natl Acad Sci U S A. 2021;118.","DOI":"10.1073\/pnas.2100356118"},{"key":"552_CR139","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/ni.1706","volume":"10","author":"LB Ivashkiv","year":"2009","unstructured":"Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol. 2009;10:340\u20137.","journal-title":"Nat Immunol"},{"key":"552_CR140","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.chembiol.2021.07.014","volume":"29","author":"SJ Ferrara","year":"2022","unstructured":"Ferrara SJ, Chaudhary P, DeBell MJ, Marracci G, Miller H, Calkins E, et al. TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor. Cell Chem Biol. 2022;29:239\u2013248 e234.","journal-title":"Cell Chem Biol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00552-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T15:28:59Z","timestamp":1676474939000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":140,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00552-w","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}